Medical Facts versus Value Judgments — Toward Preference-Sensitive Guidelines  

Oleh:

Ubel, Peter A.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 372 no. 26 (Jun. 2015), page 2475-2477.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

The radiation oncologists apologetically informed us that they would not be able to offer my wife Paula a sixth week of treatment — a “boost” therapy aimed at the place where her breast cancer had resided before she received her lumpectomy. This tumor bed was no longer localizable, because Paula had received immediate reconstruction that had obscured its location. I was aghast. Although Paula would receive 5 weeks of whole-breast irradiation, she would not receive the benefits of that final week of treatment, the boost therapy that, according to National Comprehensive Cancer Network (NCCN) guidelines, is “recommended” for women like Paula, whose breast cancer is diagnosed before they are 50 years of age and who have axillary involvement.1

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali